ARTIFICIAL INTELLIGENCE FOR DRUG DISCOVERY, BIOMARKER DEVELOPMENT & AGING RESEARCH
Our Mission is to extend healthy longevity through innovative AI solutions for drug discovery and aging research.
We aspire to be a leader in the field of deep learning for drug discovery, personalized healthcare and anti-aging interventions.
AI Pharma Pipeline
We developed a comprehensive drug discovery engine, which utilizes millions of samples and multiple data types to discover signatures of disease and identify the most promising targets for billions of molecules that already exist or can be generated de novo with the desired set of parameters.
Pharmaceutical Pipeline Leads
Nutraceutical Pipeline Leads
Services & Collaborations
We provide services to academia, pharmaceutical and cosmetics companies:
Advanced deep learning solutions
Custom drug discovery engines
Custom biomarkers discovery
New tools for aging research
Bridging the pharmaceutical and consumer industries
Awards & Recognition
We will provide customers with the industry-leading services, based on our extensive experience and proven track-record in innovative computational technology
Oct. 30, 2017, London, UK: Biogerontology Research Foundation (bg-rf.org.uk) Chief Science Officer, Dr. Alex Zhavoronkov and Biogerontology Research Foundation Advisor and Head of Business Development for Juvenescence ...
Insilico Medicine, a leader in the field of artificial intelligence, will present at the Singularity University Exponential Medicine Program in San Diego on Wednesday November 8 in Session XVIII - Future of Pharma
Insilico Medicine is adapting best neural network architectures. These advances are usually integrated into a comprehensive drug discovery pipeline with the goal to enable the deep neural networks to produce perfect ...
Nvidia is on a quest to find the best "social impact" artificial intelligence startups as part of a program called Nvidia Inception, which is screening more than 600 entrants to cull the best AI startups in three big categories.